Page last updated: 2024-09-03

y 27632 and Bright Disease

y 27632 has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishizawa, S; Kanazawa, Y; Kawanami, D; Matoba, K; Utsunomiya, K; Yokota, T	1

Other Studies

1 other study(ies) available for y 27632 and Bright Disease

Article	Year
Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. Biochemical and biophysical research communications, 2010, Nov-26, Volume: 402, Issue:4 Topics: Amides; Animals; Cell Line; Chemokine CCL2; Chemotaxis; Enzyme Inhibitors; Glomerulonephritis; Mesangial Cells; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; rho-Associated Kinases; Signal Transduction; Tumor Necrosis Factor-alpha	2010

Article

Year

Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells.

Biochemical and biophysical research communications, 2010, Nov-26, Volume: 402, Issue:4

Topics: Amides; Animals; Cell Line; Chemokine CCL2; Chemotaxis; Enzyme Inhibitors; Glomerulonephritis; Mesangial Cells; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; rho-Associated Kinases; Signal Transduction; Tumor Necrosis Factor-alpha

2010